Ignite Creation Date:
2024-05-05 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00689273
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2008-05-30
Brief Title:
Randomized Double-Blind Placebo-Controlled Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A 2-WEEK RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PARALLEL-GROUP PHASE 2 MULTICENTER STUDY OF PF-04136309 IN SUBJECTS WITH OSTEOARTHRITIC PAIN OF THE KNEE
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the efficacy safety tolerability pharmacodynamics and pharmacokinetics in patients with osteoarthritic pain of the knee The most painful knee joint will be identified as the index joint at screening and this joint will be used for all pain assessments throughout the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None